Skip to main content

23-12-2015 | Rheumatoid arthritis | Book Chapter | Article

3. Overview of Biologic Therapies

Author: Ronald F. van Vollenhoven

Publisher: Springer International Publishing


The discovery of the technology for producing monoclonal antibodies by Kohler and Milstein in 1975 heralded a new era in therapeutics: it became possible to design a molecule with a very specific predetermined biological effect for use in a relevant disease. Applications of the technology rapidly entered the medical fields of oncology and transplantation medicine.

Please log in to get access to this content

Related topics

Image Credits